prism 4 version 4.02 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
prism 4 version 4.02
Prism 4 Version 4.02, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4+version+4%2E02/prism+software/pm27063456-91-5-4
Average 90 stars, based on 1 article reviews
Prism 4 Version 4.02, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4+version+4%2E02/prism+software/pm27063456-91-5-4
Average 90 stars, based on 1 article reviews
prism 4 version 4.02 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Efficient elimination of nonstoichiometric enzyme inhibitors from HTS hit lists. Article Snippet: Dose-response curves were analyzed using GraphPad Article Title: Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease. Article Snippet: In this study, we evaluated the potential beneficial effects of antagonizing prostaglandin E2 (PGE2) EP1 receptor on motor and memory deficits in Huntington's disease (HD).. To this aim, we implanted an osmotic mini-pump system to chronically administrate an EP1 receptor antagonist (SC51089) in the R6/1 mouse model of HD, from 13 to 18 weeks of age, and used different paradigms to assess motor and memory function.. SC-51089 administration ameliorated motor coordination and balance dysfunction in R6/1 mice as analyzed by rotarod, balance beam, and vertical pole tasks. Article Title: Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease. Article Snippet: All graphswere created with Article Title: Differential toxicological response to positively and negatively charged nanoparticles in the rat brain. Article Snippet: We investigated the potential for systemic and local toxicity after administration of empty nanosized anionic and cationic PEGylated-micelles and non-PEGylated liposomes, without a ligand attached, intended for use in drug-delivery systems.. The particles were administered to 5–6-week-old male rats by three intravenous (IV) administrations over a period of one week at a dose of 100 mg/kg bodyweight or after a single intracerebroventricular (ICV) injection at a dose of 50 mg.. The particles were stable and well characterised with respect to size and zeta potential. |